VICTORY CAPITAL MANAGEMENT INC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 11:06 am Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 1,155,516 5.710% | 305,319 (+35.91%) | Filing |
| 2023-01-31 1:51 pm Sale | 2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,197 5.050% | -167 (-0.02%) | Filing |
| 2022-02-02 09:55 am Unchanged | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,364 5.830% | 0 (Unchanged) | Filing |
| 2022-01-04 12:37 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,364 5.830% | -1,560 (-0.18%) | Filing |
| 2021-03-08 11:05 am Purchase | 2021-02-28 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 851,924 12.730% | 851,924 (New Position) | Filing |